Cardiovascular Diseases Clinical Trial
Official title:
Adaptive Internet-based Stress Management Among Adults With a Cardiovascular Disease: A Pilot Sequential Multiple Assignment Randomized Trial (SMART) Design
Verified date | November 2019 |
Source | St. Mary's Research Center, Canada |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Internet-based stress management programs adapted to patients' needs
Stress is inevitable, and it has many negative consequences on the health of everybody, but
particularly on the health of patients with a cardiovascular disease (CVD). The good news is
that patients with CVD can learn to better control their stress through stress management
programs. Most stress management programs are offered face-to-face by a trained health care
professional. Research has shown that these programs have a positive impact on the health of
patients with CVD, including reducing mortality and other risk factors that can make the
disease worse (e.g., reduces blood pressure). Because of these benefits, the recommendation
is to offer a stress management program to as many patients with CVD as possible. The problem
is that their delivery is challenging for most clinics (e.g., too costly to run, health care
professionals are not available). This means many good stress management programs never make
it to the patient. Patients also face barriers in accessing traditional stress management
programs such as stigma or need to travel. Therefore, new approaches are needed to allow
findings from research to actually have an impact on the public's health.
One of these approaches is to use the internet to deliver stress management programs. The
internet has now been used for about 10 years to deliver a range of programs to patients.
There are limitations to this approach as well. For instance, 40-60% of patients who will use
an internet-based program will not benefit from it. These patients need more support or
guidance to get the most out of their internet-based program. This is the problem addressed
using the proposed innovative trial design. Investigators aim to improve the number of
patients with CVD who improve after receiving a stress management program by changing the
type and level of support they receive over time. This type of innovative trial design is
more and more popular, but has never been used to enhance a stress management programs for
patients with CVD.
Status | Completed |
Enrollment | 59 |
Est. completion date | August 31, 2019 |
Est. primary completion date | February 28, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - physician-confirmed diagnosis of a CVD (at least 3 months since most recent diagnosis) - moderate stress as indicated by a score of > 15 on the stress subscale of the Depression, Anxiety, and Stress Scale (DASS) - regular access to a computer with Internet and e-mail capabilities - understands English or French Exclusion Criteria: - participated in a stress management program in the past year - hospitalized or living in a long-term care residence - moderate-severe cognitive impairment (Blessed Orientation-Memory-Concentration test score 10+) - severe stress (DASS stress score > 34) - suicidal intent |
Country | Name | City | State |
---|---|---|---|
Canada | St Mary's Hospital Centre | Montréal | Quebec |
Lead Sponsor | Collaborator |
---|---|
St. Mary's Research Center, Canada | McGill University |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Stress | Measured with the Depression, Anxiety, and Stress Scale | At T0 (Baseline), T1 (6 weeks) and T2 (12-13 weeks) | |
Other | Quality of life | Measured with the SF-12 | At T0 (Baseline), T1 (6 weeks) and T2 (12-13 weeks) | |
Primary | Feasibility | defined as the practicality of implementing the SMART procedures and of offering different types and levels of support in conjunction with an Internet-based stress management program. Feasibility measures include fidelity, reach, recruitment rate, and questionnaire completion rates. | Recruitment over 6 months, participant follow-up over 13 weeks | |
Primary | Acceptability | defined as patients' views of the programs, and will include satisfaction with the different types of support offered, appropriateness of adapting the programs for non-responders, examining attrition, and assessing adherence and skills learned. | Recruitment over 6 months, participant follow-up over 13 weeks | |
Secondary | Clinical significance | clinical significance of adapting the type and level of support provided on the primary and secondary outcomes of interest. | At T2: 12-13 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|